2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Keele University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial Amiloride, Riluzole, Fluoxetine - Secondary Progressive Multiple Sclerosis | Phase 2 | Completed | University College, London | 445 | 2014-12-18 | 2020-03-26 |
| Early Use of Botulinum Toxin in Spasticity Post Stroke. onabotulinumtoxinA, Placebo - Stroke, Muscle Spasticity | Phase 2 | Completed | Sandwell & West Birmingham Hospitals NHS Trust | 120 | 2012-01-01 | 2014-11-18 |
Contracture (1) · Multiple Sclerosis, Chronic Progressive (1) · Muscle Spasticity (1) · Stroke (1)
Amiloride (1) · Botulinum Toxins, Type A (1) · Fluoxetine (1) · Riluzole (1)
United Kingdom (2)
Anand D Pandyan, PhD (1) · Jeremy Chataway (1) · Siddharthan Chandran (1) · Stephen G Sturman, MB ChB (1)
PMID 30166303, PMID 31981516, PMID 33040610, PMID 35945550, PMID 36325678, PMID 39262426